Latest Breaking News On - Lixte biotechnology holdings - Page 1 : comparemela.com

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) Short Interest Update

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW – Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 500 shares, an increase of 150.0% from the March 31st total of 200 shares. Based on an average trading volume of 3,000 […]

Nasdaq
Lixte-biotechnology-holdings-inc
Lixte-biotechnology-company-profile
Lixte-biotechnology-holdings
Get-free-report
Biotechnology-holdings
Lixte-biotechnology-daily
Lixte-biotechnology
Nasdaq-lixtw
Lixtw
Medical

Clearside Biomedical And 3 Other Stocks Under $3 Insiders Are Buying - Clearside Biomedical (NASDAQ:CLSD), Glatfelter (NYSE:GLT)

The Dow Jones closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Duane-clint-carlson
Nancy-hutson
Rene-bernards
Glatfelter-corporation
Najeeb-ghauri
Lixte-biotechnology-holdings-inc
Clearside-biomedical-inc
Ekman-co
Technologies-inc
Netsol-technologies-inc
Glatfelter
Dow-jones

LIXTE Appoints Bas van der Baan as President and Chief Executive Officer

Lixte Biotechnology Holdings, Inc. Bas van der Baan, Newly Appointed President, CEO, Vice Chairman, LIXTE Biotechnology Holdings Biotechnology Veteran Bas van der Baan Brings Precision Oncology Expertise; Founder John S. Kovach Named Executive Chairman PASADENA, CA, Sept. 26, 2023 (GLOBE NEWSWIRE) LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage biotechnology company developing a novel class of cancer therapy called PP2A inhibitors, anno

Netherlands
Irvine
California
United-states
Amsterdam
Noord-holland
Johns-kovach
Flaurie-berman
Agendia-inc
Pondelwilkinson-inc
Business-development
Biotechnology-holdings-inc

Lixte Biotechnology Holdings, Inc. (LIXT) Announces 583K Share Offering by Selling Stockholders

Lixte Biotechnology Holdings, Inc. (LIXT) Announces 583K Share Offering by Selling Stockholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nasdaq
Lixte-biotechnology-holdings-inc
Lixte-biotechnology-holdings

Short Interest in Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) Decreases By 28.7%

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Get Free Report) saw a large decrease in short interest in June. As of June 30th, there was short interest totalling 8,700 shares, a decrease of 28.7% from the June 15th total of 12,200 shares. Based on an average trading volume of 20,700 shares, the short-interest ratio is presently […]

Nasdaq
Geode-capital-management
Ep-wealth-advisors
Lixte-biotechnology-holdings-inc
Ethos-financial-group
Lixte-biotechnology-company-profile
Renaissance-technologies
Lixte-biotechnology-holdings
Get-free-report
Biotechnology-stock-down
Lixte-biotechnology